Concepedia

Yutaka Okawa

YO

30

Publications

2.8K

Citations

20

H-Index

1985

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Jikei University School of Medicine

Massachusetts General Hospital

Sapporo Medical University

Yutaka Okawa is an author at Dana-Farber Cancer Institute specializing in cell biology, medicine, and cancer research.

Top concepts

Publications per year

1985–2015

30

Publications

30

Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells

Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan et al. · Blood · 2009 · 364 citations · Full text

3D niche microarrays for systems-level analyses of cell fate

Adrian Ranga, Samy Gobaa, Yutaka Okawa et al. · Nature Communications · 2014 · 235 citations · Full text

SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK

Yutaka Okawa, Teru Hideshima, Paul M. Steed et al. · Blood · 2008 · 208 citations · Full text

Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

Iris Breitkreutz, Marc S. Raab, Sonia Vallet et al. · Leukemia · 2008 · 208 citations

, , +8

The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells <i>In vitro</i> and <i>In vivo</i>

Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti et al. · Clinical Cancer Research · 2009 · 204 citations · Full text

Rows per page

1–5 of 30